Clinical Trials
93 trialsBio-lung
University Hospital, Lille
ECP
Centre Chirurgical Marie Lannelongue
LUNG-RESIST
University Hospital, Toulouse
KOBE
University Hospital, Toulouse
RESAMEX
Groupe Francais De Pneumo-Cancerologie
OPTALK
Groupe Francais De Pneumo-Cancerologie
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Vanderbilt-Ingram Cancer Center
Circulating Tumor Cells (CTC) in Lung Cancer
Indiana University
COMETH
University of Kansas Medical Center
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
Wake Forest University Health Sciences
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
Wake Forest University Health Sciences
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
RICEPS-2
University Hospital, Tours
MetLung
Centre Oscar Lambret
ELEPHAS-04
Mayo Clinic
PneumoTAV001
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
DuTOC
Dutch Society of Physicians for Pulmonology and Tuberculosis
Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer
The Netherlands Cancer Institute
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
The Institute of Molecular and Translational Medicine, Czech Republic
B-GLUCANCER2
Poitiers University Hospital
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
Memorial Sloan Kettering Cancer Center
BREATHE
Nantes University Hospital
CLASSE-P1
Assistance Publique - Hôpitaux de Paris
LUNGDOC
University Hospital, Montpellier
ULYSSE
Hospices Civils de Lyon
DECIDE
Institut Claudius Regaud
MADMAS
Hospices Civils de Lyon
RESISTYR
Rennes University Hospital
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
Hasselt University
CIRCUIT
University Hospital, Bordeaux
BCBPoumon
Institut du Cancer de Montpellier - Val d'Aurelle
IPON-3
Maastricht Radiation Oncology
PROGRESS
UNC Lineberger Comprehensive Cancer Center
NEO-TAN
University Hospital, Montpellier
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Stanford University
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
University of Arkansas
Genetic Susceptibility to Lung Cancer in Never Smokers
Memorial Sloan Kettering Cancer Center
The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery
Universitair Ziekenhuis Brussel
EXODIAG
Centre Georges Francois Leclerc
UMBRELLA
Gustave Roussy, Cancer Campus, Grand Paris
ALCINA2
Institut du Cancer de Montpellier - Val d'Aurelle
EGFR Lung Canc
Our Lady of the Lake Hospital
FUTURE
Assistance Publique Hopitaux De Marseille
Lymphocyte Depletion and Change in Lymphocyte Functionality
University of Virginia
CANTO
UNICANCER
ARIA
Scientific Institute San Raffaele
LUTON
Hospices Civils de Lyon
BIOCEPTION
Assistance Publique Hopitaux De Marseille
PREVALUNG*
Assistance Publique Hopitaux De Marseille
PROTEON
Centre Hospitalier Universitaire de Liege